Uploaded October 2024 | Updated November 2026, 1 hour ago
Scientists at the University of Padova have found that a small molecule known as 1-Piperidine Propionic Acid (1-PPA) is capable of blocking the Protease Activated Receptor 2 (PAR2) signalling pathway involved in the development of cancer. 1-PPA is a proposed novel treatment for cancers expressing the protein known as SerpinB3.
See our T&Cs: sciani.com/terms-conditions
━━━━━━━━━━━━━━━━━━━━
Additional Information
────────────────────────────
doi.org/10.1016/j.molmet.2024.101889
━━━━━━━━━━━━━━━━━━━
Science Animated
────────────────────────────
sciani.com
twitter.com/Sci_Ani
facebook.com/scianimation
sciani.com/terms-conditions
━━━━━━━━━━━━━━━━━━━━
#cancertreatments
#cancerresearch
#liverdisease
Scientists at the University of Padova have found that a small molecule known as 1-Piperidine Propionic Acid (1-PPA) is capable of blocking the Protease Activated Receptor 2 (PAR2) signalling pathway involved in the development of cancer. 1-PPA is a proposed novel treatment for cancers expressing the protein known as SerpinB3.
See our T&Cs: sciani.com/terms-conditions
━━━━━━━━━━━━━━━━━━━━
Additional Information
────────────────────────────
doi.org/10.1016/j.molmet.2024.101889
━━━━━━━━━━━━━━━━━━━
Science Animated
────────────────────────────
sciani.com
twitter.com/Sci_Ani
facebook.com/scianimation
sciani.com/terms-conditions
━━━━━━━━━━━━━━━━━━━━
#cancertreatments
#cancerresearch
#liverdisease










